BMC GenomicsGenetic & Genomic MedicinePeer-reviewed journal article
Proteomic Networks and Related Genetic Variants Associated with Smoking and Chronic Obstructive Pulmonary Disease
Iain R. KonigsbergiD, Thao VuiD, W. M. LiuiD, ELIZABETH M. LITKOWSKIiD, Katherine PratteiD, Luciana B. VargasiD, Niles Gilmore, Mohamed Abdel-Hafiz, Ani W ManichaikuliD, Michael H. ChoiD, Craig P. HershiD, Dawn Lisa DeMeoiD, Farnoush Banaei‐KashaniiD, Russell Paul BowleriD, Leslie A. LangeiD, Katerina J. KechrisiD
Abstract
BackgroundStudies have identified individual blood biomarkers associated with chronic obstructive pulmonary disease (COPD) and related phenotypes. However, complex diseases such as COPD typically involve changes in multiple molecules with interconnections that may not be captured when considering single molecular features. MethodsLeveraging proteomic data from 3,173 COPDGene Non-Hispanic White (NHW) and African American (AA) participants, we applied sparse multiple canonical correlation network analysis (SmCCNet) to 4,776 proteins assayed on the SomaScan v4.0 platform to derive sparse networks of proteins associated with current vs. former smoking status, airflow obstruction, and emphysema quantitated from high-resolution computed tomography scans. We then used NetSHy, a dimension reduction technique leveraging network topology, to produce summary scores of each proteomic network, referred to as NetSHy scores. We next performed genome-wide association study (GWAS) to identify variants associated with the NetSHy scores, or network quantitative trait loci (nQTLs). Finally, we evaluated the replicability of the networks in an independent cohort, SPIROMICS. ResultsWe identified networks of 13 to 104 proteins for each phenotype and exposure in NHW and AA, and the derived NetSHy scores significantly associated with the variable of interests. Networks included known (sRAGE, ALPP, MIP1) and novel molecules (CA10, CPB1, HIS3, PXDN) and interactions involved in COPD pathogenesis. We observed 7 nQTL loci associated with NetSHy scores, 4 of which remained after conditional analysis. Networks for smoking status and emphysema, but not airflow obstruction, demonstrated a high degree of replicability across race groups and cohorts. ConclusionsIn this work, we apply state-of-the-art molecular network generation and summarization approaches to proteomic data from COPDGene participants to uncover protein networks associated with COPD phenotypes. We further identify genetic associations with networks. This work discovers protein networks containing known and novel proteins and protein interactions associated with clinically relevant COPD phenotypes across race groups and cohorts.
- organism: human
- assay: proteomics
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 5
- FWCI
- 1.45
- Field percentile
- top 17%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Newly identified COPD GWAS protein interactors reveal a potential disease network module
Dávid Deritei, Hiroyuki Inuzuka, … Edwin K. Silverman·bioRxiv·Sep 18, 2026
- De novo discovery of traits co-occurring with chronic obstructive pulmonary disease
Evgeniia Golovina, Tayaza Fadason, … Justin Martin O'Sullivan·Life Science AlliancePeer-reviewed·Dec 27, 2022
- Integrated transcriptomic correlation network analysis identifies COPD molecular determinants
Paola Paci, Giulia Fiscon, … Lorenzo Farina·Scientific ReportsPeer-reviewed·Feb 25, 2020
- Integrative Omics Reveal Novel Protein Targets For Chronic Obstructive Pulmonary Disease Biomarker Discovery
Ana I. Hernández Cordero, Stephen B Milne, … Ma’en Obeidat·medRxiv·Jan 11, 2021
- Proteomic network analysis of bronchoalveolar lavage fluid in ex-smokers to discover implicated protein targets and novel drug treatments for chronic obstructive pulmonary disease
Manoj J. Mammen, Chengjian Tu, … Ram Samudrala·PharmaceuticalsPeer-reviewed·May 1, 2022
- Network-guided identification of candidate biomarkers for COPD-associated comorbidities using deep learning and real-world transcriptomic data
José Manuel Mas, Esther Ramírez, Xavier Daura·bioRxiv·Oct 30, 2026